Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $16.48 million. The enterprise value is $9.07 million.
| Market Cap | 16.48M |
| Enterprise Value | 9.07M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 1.03 million shares outstanding. The number of shares has increased by 1,943.58% in one year.
| Shares Outstanding | 1.03M |
| Shares Change (YoY) | +1,943.58% |
| Shares Change (QoQ) | +850.06% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 6.33% |
| Float | 860,975 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.57 |
| Forward PS | n/a |
| PB Ratio | 2.26 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82, with zero debt.
| Current Ratio | 1.82 |
| Quick Ratio | 1.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.23 |
Financial Efficiency
Return on equity (ROE) is -1,439.90% and return on invested capital (ROIC) is -374.47%.
| Return on Equity (ROE) | -1,439.90% |
| Return on Assets (ROA) | -113.90% |
| Return on Capital (ROIC) | -374.47% |
| Revenue Per Employee | $101,263 |
| Profits Per Employee | -$1.66M |
| Employee Count | 19 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $14,000 in taxes.
| Income Tax | 14,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.80% in the last 52 weeks. The beta is 1.17, so AVTX's price volatility has been higher than the market average.
| Beta (1Y) | 1.17 |
| 52-Week Price Change | -97.80% |
| 50-Day Moving Average | 9.08 |
| 200-Day Moving Average | 21.30 |
| Relative Strength Index (RSI) | 61.85 |
| Average Volume (30 Days) | 679,940 |
Short Selling Information
The latest short interest is 153,399, so 14.83% of the outstanding shares have been sold short.
| Short Interest | 153,399 |
| Short Previous Month | 78,474 |
| Short % of Shares Out | 14.83% |
| Short % of Float | 17.82% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, AVTX had revenue of $1.92 million and -$31.54 million in losses. Loss per share was -$114.00.
| Revenue | 1.92M |
| Gross Profit | 640,000 |
| Operating Income | -27.35M |
| Pretax Income | -31.53M |
| Net Income | -31.54M |
| EBITDA | -27.96M |
| EBIT | -28.11M |
| Loss Per Share | -$114.00 |
Balance Sheet
The company has $7.42 million in cash and no debt, giving a net cash position of $7.42 million or $7.17 per share.
| Cash & Cash Equivalents | 7.42M |
| Total Debt | n/a |
| Net Cash | 7.42M |
| Net Cash Per Share | $7.17 |
| Equity / Book Value | 7.30M |
| Book Value Per Share | 7.06 |
| Working Capital | 3.78M |
Cash Flow
In the last 12 months, operating cash flow was -$30.68 million and capital expenditures -$133,000, giving a free cash flow of -$30.81 million.
| Operating Cash Flow | -30.68M |
| Capital Expenditures | -133,000 |
| Free Cash Flow | -30.81M |
| FCF Per Share | -$38.44 |
Margins
Gross margin is 33.26%, with operating and profit margins of -1,421.57% and -1,639.50%.
| Gross Margin | 33.26% |
| Operating Margin | -1,421.57% |
| Pretax Margin | -1,638.77% |
| Profit Margin | -1,639.50% |
| EBITDA Margin | -1,452.96% |
| EBIT Margin | -1,461.17% |
| FCF Margin | -1,601.51% |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,943.58% |
| Shareholder Yield | -1,943.58% |
| Earnings Yield | -191.36% |
| FCF Yield | -186.93% |
Analyst Forecast
The average price target for AVTX is $107.50, which is 574.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $107.50 |
| Price Target Difference | 574.40% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | -14.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of -25.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.74 |
| Piotroski F-Score | 2 |